{{cartTotalQuantity}}
Molekulardiagnostik-Menü
Instrumente und Software
Die Lösungen von Cepheid
Tests an jedem Ort
Antibiotic Stewardship
Cepheid’s Insights
Webinare
Cepheid RADAR
Support Center
Kontaktaufnahme
Über Cepheid
Mission und Geschichte
Veranstaltungen
Vertriebspartner
Zusammenarbeit mit Cepheid
Innovation bei Cepheid
Das Cepheid Motorrad
Neuigkeiten
Unser Leitungsteam
Karriere
Lesedauer von 5 Min.
07. Januar 2026
Lesedauer von 6 Min.
02. Juni 2026
Lesedauer von 3 Min.
02. Juni 2026
Lesedauer von 6 Min.
09. September 2026
Artikel
Researchers analyzing multiplex gastrointestinal (GI) panel results found that multiple E. coli pathotypes were frequently detected alongside other enteric pathogens, potentially complicating data interpretation.
The findings were presented at the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Clinical Lab Expo.
Wichtigste Erkenntnisse
Study Summary
This retrospective analysis used Truveta electronic health record data (53,757 encounters) to evaluate patients tested with multiplex GI panels in acute care settings, including emergency departments and inpatient units. Researchers identified panels using CPT and LOINC codes, then assessed the five most frequent pathogens co-detected with EPEC, EAEC, and ETEC. Co-detection was defined as two or more pathogens reported on a single panel, with prevalence calculated among patients tested for both organisms. The analysis found that E. coli pathotypes were commonly detected with viral and bacterial pathogens. This co-detection can complicate interpretation and may influence inappropriate antibiotic prescribing, especially when the pathogenic role of E. coli is unclear.
The Challenge
Multiplex GI panels can rapidly detect a broad range of organisms, but broad detection can also introduce interpretation challenges. This is especially true when organisms such as EPEC or EAEC may represent colonization rather than the primary cause of symptoms. When these findings appear alongside viral pathogens or other bacteria, clinicians may face uncertainty about which result is clinically actionable.
The Insight
"Detection alone does not always identify the causative pathogen,” said lead study author, Anita Mohandas. “When E. coli pathotypes are found alongside viral or bacterial organisms, clinical context becomes essential for determining whether treatment is warranted."
Fazit
This study underscores a practical challenge in syndromic GI testing: more detection does not always mean clearer clinical direction. Frequent E. coli co-detections, particularly with viral pathogens, highlight the need for careful interpretation, clinician education, and panel design that prioritizes clinically actionable results.
Abkürzungen
EPEC enteropathogenic E. coli; EAEC enteroaggregative E. coli; ETEC enterotoxigenic E. coli; DEC diarrheagenic E. coli; CPT Current Procedural Terminology; LOINC Logical Observation Identifiers Names and Codes
Möchten Sie mehr erfahren?
Authors: Anita Mohandas, MSc, MHPª; Riley Zambrano, MScª; Jordan Chase, BAª; Christophe Martinaud, MD, PhDª
ªCepheid, Sunnyvale, CA, USA
ADLM 2026. Poster A-305
Die auf dieser Seite präsentierten Inhalte dienen zu Informations- und Bildungszwecken. Obwohl es weltweit verfügbar ist, kann es klinische Praktiken oder Aspekte des Gesundheitssystems widerspiegeln, die für eine bestimmte Region spezifisch sind.
MEHR